SQI Diagnostics Receives $2.3 Million in Funds from Shareholder Exercise of Securities
Share this article Company Continues to Improve Gross Cash Position to Execute Business Plan TORONTO, March 8, 2021 /PRNewswire/ - SQI Diagnostics Inc. (the "Company" or "SQI") (TSXV: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops, and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, announces that 9,775,972 common share purchase warrants (the Warrants") and 1,500,000 stock options (the "Options") have been exercised at exercise prices between $0.09 and $0.30 per common shares since January 1, 20...
Source: prnewswire.com